First Annual US-China Health Economy Business Forum
The US and China Seek Common Ground by Improving Public Health
The US-China Business Council (USCBC) and China Chamber of International Commerce (CCOIC) successfully concluded the First Annual US-China Health Economy Business Forum on July 29. The forum brought together world-leading innovators and providers of medicines and health services to discuss the future of healthcare delivery in China.
Chaired by USCBC Vice President Matthew Margulies and CCOIC Secretary General Yu Jianlong, the forum underscored the critical role that the US and Chinese business communities continue to play in contributing to COVID-19 recovery efforts and finding new areas for cooperation and collaboration.
In his remarks, Margulies noted that, “US and Chinese companies continue to serve as the ballast in the bilateral US-China relationship, which, in light of COVID-19, is especially true for healthcare-related industries.” Secretary General Yu Jianlong shared those sentiments and expressed that, “It is of great significance to discuss opportunities and policy challenges between the two countries to encourage pharmaceutical innovation and the strengthening of cooperation in commercial health insurance to fully meet peoples’ medical needs.”
The virtual forum brought together representatives of leading American and Chinese biopharmaceutical, healthcare services delivery, and commercial insurance companies, and was also supported by the US Cooperative for International Patient Programs (USCIPP). Officials from China’s National Development and Reform Commission, Ministry of Finance, Ministry of Commerce, State Administration of Market Regulation, Insurance and Banking Regulatory Commission, National Medical Products Administration, National Intellectual Property Administration, Food and Drug International Exchange Center, and Medical Products Import and Export Association also participated in the forum.
The US and China Seek Common Ground by Improving Public Health
The US-China Business Council (USCBC) and China Chamber of International Commerce (CCOIC) successfully concluded the First Annual US-China Health Economy Business Forum on July 29. The forum brought together world-leading innovators and providers of medicines and health services to discuss the future of healthcare delivery in China.
Chaired by USCBC Vice President Matthew Margulies and CCOIC Secretary General Yu Jianlong, the forum underscored the critical role that the US and Chinese business communities continue to play in contributing to COVID-19 recovery efforts and finding new areas for cooperation and collaboration.
In his remarks, Margulies noted that, “US and Chinese companies continue to serve as the ballast in the bilateral US-China relationship, which, in light of COVID-19, is especially true for healthcare-related industries.” Secretary General Yu Jianlong shared those sentiments and expressed that, “It is of great significance to discuss opportunities and policy challenges between the two countries to encourage pharmaceutical innovation and the strengthening of cooperation in commercial health insurance to fully meet peoples’ medical needs.”
The virtual forum brought together representatives of leading American and Chinese biopharmaceutical, healthcare services delivery, and commercial insurance companies, and was also supported by the US Cooperative for International Patient Programs (USCIPP). Officials from China’s National Development and Reform Commission, Ministry of Finance, Ministry of Commerce, State Administration of Market Regulation, Insurance and Banking Regulatory Commission, National Medical Products Administration, National Intellectual Property Administration, Food and Drug International Exchange Center, and Medical Products Import and Export Association also participated in the forum.
